Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

NYSE:COHR - New York Stock Exchange, Inc. - US19247G1076 - Common Stock - Currency: USD

81.36  -0.15 (-0.18%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to COHR. COHR was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and the financial health of COHR get a neutral evaluation. Nothing too spectacular is happening here. COHR is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year COHR was profitable.
COHR had a positive operating cash flow in the past year.
In multiple years COHR reported negative net income over the last 5 years.
In the past 5 years COHR always reported a positive cash flow from operatings.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.22%, COHR is in line with its industry, outperforming 49.60% of the companies in the same industry.
The Return On Equity of COHR (-0.41%) is comparable to the rest of the industry.
COHR's Return On Invested Capital of 3.37% is in line compared to the rest of the industry. COHR outperforms 57.60% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COHR is significantly below the industry average of 9.35%.
The 3 year average ROIC (2.57%) for COHR is below the current ROIC(3.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROIC 3.37%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

COHR's Operating Margin of 9.86% is fine compared to the rest of the industry. COHR outperforms 80.00% of its industry peers.
In the last couple of years the Operating Margin of COHR has declined.
The Gross Margin of COHR (34.48%) is comparable to the rest of the industry.
COHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.86%
PM (TTM) N/A
GM 34.48%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COHR is destroying value.
The number of shares outstanding for COHR has been increased compared to 1 year ago.
Compared to 5 years ago, COHR has more shares outstanding
The debt/assets ratio for COHR has been reduced compared to a year ago.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 1.91 indicates that COHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
COHR's Altman-Z score of 1.91 is on the low side compared to the rest of the industry. COHR is outperformed by 72.80% of its industry peers.
COHR has a debt to FCF ratio of 14.56. This is a negative value and a sign of low solvency as COHR would need 14.56 years to pay back of all of its debts.
COHR has a Debt to FCF ratio (14.56) which is comparable to the rest of the industry.
COHR has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.48, COHR is not doing good in the industry: 71.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Altman-Z 1.91
ROIC/WACC0.36
WACC9.36%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

COHR has a Current Ratio of 2.47. This indicates that COHR is financially healthy and has no problem in meeting its short term obligations.
COHR has a Current ratio (2.47) which is in line with its industry peers.
COHR has a Quick Ratio of 1.54. This is a normal value and indicates that COHR is financially healthy and should not expect problems in meeting its short term obligations.
COHR has a Quick ratio (1.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.54
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.86% over the past year.
COHR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.30% yearly.
The Revenue has grown by 21.67% in the past year. This is a very strong growth!
COHR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.14% yearly.
EPS 1Y (TTM)119.86%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%71.7%
Revenue 1Y (TTM)21.67%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%23.92%

3.2 Future

COHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.77% yearly.
Based on estimates for the next years, COHR will show a quite strong growth in Revenue. The Revenue will grow by 13.04% on average per year.
EPS Next Y115.5%
EPS Next 2Y64.53%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue Next Year23.87%
Revenue Next 2Y16.41%
Revenue Next 3Y13.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.35, which means the current valuation is very expensive for COHR.
64.80% of the companies in the same industry are more expensive than COHR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.55. COHR is around the same levels.
Based on the Price/Forward Earnings ratio of 18.11, the valuation of COHR can be described as rather expensive.
68.00% of the companies in the same industry are more expensive than COHR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.40. COHR is around the same levels.
Industry RankSector Rank
PE 25.35
Fwd PE 18.11
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COHR is valued a bit cheaper than 68.00% of the companies in the same industry.
COHR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.35
EV/EBITDA 13.92
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COHR's earnings are expected to grow with 48.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y64.53%
EPS Next 3Y48.77%

More info and screens

0

5. Dividend

5.1 Amount

COHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COHERENT CORP

NYSE:COHR (6/12/2025, 11:22:06 AM)

81.36

-0.15 (-0.18%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-13 2025-08-13/amc
Inst Owners93.24%
Inst Owner Change0.44%
Ins Owners0.62%
Ins Owner Change-1.1%
Market Cap12.65B
Analysts81.48
Price Target98.12 (20.6%)
Short Float %4.7%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.23%
Min EPS beat(2)4.19%
Max EPS beat(2)34.28%
EPS beat(4)4
Avg EPS beat(4)14.27%
Min EPS beat(4)0.45%
Max EPS beat(4)34.28%
EPS beat(8)8
Avg EPS beat(8)19.29%
EPS beat(12)11
Avg EPS beat(12)12.37%
EPS beat(16)15
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.9%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)1.44%
Min Revenue beat(4)0.53%
Max Revenue beat(4)2.33%
Revenue beat(8)6
Avg Revenue beat(8)0.91%
Revenue beat(12)7
Avg Revenue beat(12)-0.4%
Revenue beat(16)9
Avg Revenue beat(16)-0.61%
PT rev (1m)1.87%
PT rev (3m)-17.51%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)1.4%
EPS NY rev (3m)1.28%
Revenue NQ rev (1m)2.13%
Revenue NQ rev (3m)2.13%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)1.71%
Valuation
Industry RankSector Rank
PE 25.35
Fwd PE 18.11
P/S 2.26
P/FCF 49.35
P/OCF 19
P/B 1.62
P/tB 171.58
EV/EBITDA 13.92
EPS(TTM)3.21
EY3.95%
EPS(NY)4.49
Fwd EY5.52%
FCF(TTM)1.65
FCFY2.03%
OCF(TTM)4.28
OCFY5.26%
SpS35.99
BVpS50.27
TBVpS0.47
PEG (NY)0.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROCE 4.26%
ROIC 3.37%
ROICexc 3.61%
ROICexgc 10.1%
OM 9.86%
PM (TTM) N/A
GM 34.48%
FCFM 4.58%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
ROICexc(3y)3.83%
ROICexc(5y)4.17%
ROICexgc(3y)8.28%
ROICexgc(5y)8.58%
ROCE(3y)3.26%
ROCE(5y)3.73%
ROICexcg growth 3Y-38.53%
ROICexcg growth 5Y-25%
ROICexc growth 3Y-46.21%
ROICexc growth 5Y-34.59%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Debt/EBITDA 3.35
Cap/Depr 72.79%
Cap/Sales 7.32%
Interest Coverage 2
Cash Conversion 59.74%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.54
Altman-Z 1.91
F-Score6
WACC9.36%
ROIC/WACC0.36
Cap/Depr(3y)78.52%
Cap/Depr(5y)70.67%
Cap/Sales(3y)8.43%
Cap/Sales(5y)7.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.86%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%71.7%
EPS Next Y115.5%
EPS Next 2Y64.53%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue 1Y (TTM)21.67%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%23.92%
Revenue Next Year23.87%
Revenue Next 2Y16.41%
Revenue Next 3Y13.04%
Revenue Next 5YN/A
EBIT growth 1Y226.98%
EBIT growth 3Y-23.16%
EBIT growth 5Y-0.2%
EBIT Next Year89.64%
EBIT Next 3Y34.79%
EBIT Next 5YN/A
FCF growth 1Y99.42%
FCF growth 3Y-22.55%
FCF growth 5Y36.88%
OCF growth 1Y12.86%
OCF growth 3Y-1.69%
OCF growth 5Y25.05%